Skip to content
Call our team Request appointment

Substance Use and Addiction Psychiatry Treatment in Melbourne, FL

Substance use disorder is a medical condition in which the use of alcohol, opioids, stimulants, cannabis, sedatives or other substances continues despite harm, with loss of control, craving, tolerance and withdrawal. It changes the brain's reward, motivation and self-control circuits, which is why willpower alone so often fails and why medication and structured treatment work. Most people with a substance use disorder also have another psychiatric condition, most often depression, anxiety, PTSD, ADHD or bipolar disorder, and treating one without the other rarely holds.

The short answer

Substance use disorder is a treatable medical condition involving continued use of alcohol, opioids or other substances despite harm. Outpatient treatment combines FDA-approved medication (naltrexone, acamprosate or disulfiram for alcohol; buprenorphine or naltrexone for opioids), therapy, and treatment of co-occurring depression, anxiety or PTSD. Medication for opioid use disorder cuts the risk of overdose death roughly in half. Stedfast Psychiatry treats substance use and addiction at 6300 North Wickham Road in Melbourne and by video across Florida; new patients call (561) 295-8859.

Substance Use and Addiction Psychiatry at our Melbourne office

If you live near Health First Viera Hospital or in Viera West, Viera East, Pineda Crossing and Palm Shores, this is your closest Stedfast Psychiatry office for substance use and addiction treatment. We also see residents of West Melbourne, Rockledge, Cocoa and Cocoa Beach who prefer not to drive farther.

Free surface parking is available in front of the building, with accessible spaces near the entrance. Suite 110 is on the ground floor. Arrive a few minutes early during school drop-off and pick-up hours, when Wickham Road traffic is heaviest. Hours are Monday to Friday, 8:00 AM to 5:00 PM, with weekend appointments by arrangement. New patients call (561) 295-8859; existing patients use (321) 977-5669.

The Melbourne office is an entry point to Stedfast Psychiatry's Deep TMS and Spravato programs. Treatment sessions run at our Palm Beach Gardens TMS center and the Palm Beach Gardens Spravato rooms, roughly 120 and 120 minutes away; the evaluation, the screening scales and the prior authorization all happen here.

Who you will see in Melbourne

The Melbourne team includes psychiatric nurse practitioners Alexandra Renninger, Hannah Sobas and Merlande Vance. Visits in Creole are available with Merlande Vance. Children and teens are seen by Merlande Vance and Megan Benda.

Alexandra Renninger, PMHNP-BC

Psychiatric Nurse Practitioner · Adults 18+

Hannah Sobas, PMHNP-BC

Psychiatric Nurse Practitioner · Adults 18 to 64

Merlande Vance, PMHNP-BC

Psychiatric Nurse Practitioner · Children 6+, teens and adults · English, Creole

Kindal Sweet

Clinician · Adults 18+; 14 to 17 on request

Megan Benda

Clinician · Adults and teens 14+; 13 on request

Signs of substance use and addiction

  • Using more or for longer than intended
  • Repeated unsuccessful attempts to cut down or stop
  • Craving or a strong urge to use
  • Spending a great deal of time obtaining, using or recovering
  • Failing to meet obligations at work, school or home
  • Continuing to use despite relationship, health or legal problems
  • Giving up activities you used to enjoy
  • Needing more to get the same effect (tolerance)

How we diagnose it

Our evaluation covers each substance used, the amount, frequency, duration and route, prior withdrawal episodes including seizures or delirium tremens, overdoses, prior treatment, and current pattern. We use standardized tools including the AUDIT for alcohol and the DAST for drugs, and we assess DSM-5-TR criteria to rate severity. We screen carefully for co-occurring depression, anxiety, PTSD, ADHD, bipolar disorder and psychosis, distinguishing substance-induced symptoms from independent conditions by their timing relative to use. Labs include liver function, a complete blood count, hepatitis B and C and HIV screening where indicated, and a urine drug screen as a clinical tool rather than a test to pass. We assess whether medically supervised withdrawal is needed, since alcohol and benzodiazepine withdrawal can be life-threatening, and whether outpatient care is the right level.

In 2023, 48.5 million Americans aged 12 and older (16.7 percent) had a substance use disorder in the past year, including 28.9 million with alcohol use disorder.

Source: SAMHSA, National Survey on Drug Use and Health 2023

Only about one in four people with a substance use disorder received any treatment in the past year.

Source: SAMHSA, National Survey on Drug Use and Health

Buprenorphine and methadone treatment reduce the risk of death from opioid overdose by roughly 50 percent.

Source: National Institute on Drug Abuse; Sordo et al., BMJ 2017

About half of people with a substance use disorder will have a co-occurring mental illness at some point, and vice versa.

Source: National Institute on Drug Abuse

Treatment for substance use and addiction in Melbourne

Medication management

For alcohol use disorder, naltrexone (daily oral or monthly Vivitrol injection) reduces craving and the reward from drinking and is first-line; acamprosate supports abstinence after withdrawal, particularly with liver disease; disulfiram creates an aversive reaction to alcohol for motivated patients with supervision; and topiramate and gabapentin are evidence-based off-label options. For opioid use disorder, buprenorphine (Suboxone, Subutex, and the monthly Sublocade or Brixadi injections) is prescribed in our offices and by telehealth, started after mild withdrawal has begun, and continued long term; it cuts overdose deaths by about half. Extended-release naltrexone is an alternative for patients who have fully detoxified. We prescribe naloxone to every patient with opioid use disorder. For tobacco, varenicline, bupropion and nicotine replacement are effective, and Deep TMS was FDA-cleared for smoking cessation in 2020. For stimulant and cannabis use disorders, no FDA-approved medication exists, and we use behavioral treatment plus medication for the co-occurring conditions driving use. We treat depression, anxiety, PTSD and ADHD concurrently, choosing medications with low misuse potential where relevant.

Psychotherapy and recovery support

Motivational interviewing helps resolve ambivalence about change. Cognitive behavioral therapy for substance use teaches you to identify triggers, manage craving and handle high-risk situations. Contingency management, which rewards verified abstinence, has the best evidence for stimulant use disorder. Trauma-focused therapy is essential when PTSD drives use. We refer to intensive outpatient programs, partial hospitalization and residential treatment when weekly care is not enough, and we support engagement with mutual-help groups including AA, NA, SMART Recovery and Refuge Recovery. Family members benefit from Al-Anon and the CRAFT approach, and we involve them when the patient agrees.

What to expect

The first visit is a 60-minute evaluation, in person or by video. We assess safety, including withdrawal risk, and agree on a plan that may include starting medication the same day, a referral for medically supervised withdrawal, therapy and recovery support. Early follow-ups are weekly or every two weeks, then monthly once stable; buprenorphine visits follow the required monitoring schedule. Telehealth visits are available across Florida and South Carolina for follow-up and, within current federal and state rules, for buprenorphine care. Your treatment is confidential under federal law (42 CFR Part 2), with stronger protections than most medical records.

The complete guide, including causes, subtypes and research, is on our Substance Use and Addiction Psychiatry page.

Emergency and crisis resources near Melbourne

In an emergency, call 911 or go to Health First Viera Hospital Emergency Department (8745 N Wickham Rd, Melbourne). The 988 Suicide and Crisis Lifeline is available by call or text 24 hours a day. Holmes Regional Medical Center Emergency Department and 988 Suicide and Crisis Lifeline are also listed on the Melbourne office page.

Frequently asked questions

Who provides substance use and addiction treatment at the Melbourne office?

The Melbourne team includes psychiatric nurse practitioners Alexandra Renninger, Hannah Sobas and Merlande Vance. Visits in Creole are available with Merlande Vance. Every provider works under psychiatrist oversight and the same evaluation standard: about an hour for a first visit, validated screening scales, and a written plan.

Can I be seen by video instead of coming to Melbourne?

Yes. Stedfast Psychiatry providers are licensed in Florida and offer video visits for evaluations and follow-ups. Some situations, including certain controlled-substance prescriptions and first visits for young children, require an in-person appointment at 6300 North Wickham Road.

Does the Melbourne office take my insurance?

We accept most major commercial plans and Medicare. Call (561) 295-8859 with your member ID and we will verify benefits before the visit. Self-pay new-patient evaluations are $185.

How soon can a new patient be seen in Melbourne?

Most new patients are scheduled within one to two weeks. If you need to be seen sooner, ask about a video visit; those often open up within days. If you are in crisis, call or text 988 or go to the nearest emergency room rather than waiting.

Can I get Deep TMS or Spravato as a Melbourne patient?

Yes. Stedfast Psychiatry is licensed for both. Your Melbourne provider does the evaluation and the prior authorization; treatment sessions are scheduled at our Palm Beach Gardens TMS center and the Palm Beach Gardens Spravato rooms.

What is the difference between an addiction psychiatrist and a rehab program?

Addiction psychiatry is outpatient medical care: diagnosis, medication such as buprenorphine or naltrexone, and treatment of the depression, anxiety or trauma that drives use, delivered in regular office or video visits while you live your life. Rehab programs (residential, partial hospitalization, intensive outpatient) provide structured daily treatment for a defined period. Many patients use both, and we refer to and coordinate with programs when the intensity is needed. Psychiatric care continues after a program ends, which is when relapse risk is highest.

Is Suboxone just replacing one addiction with another?

No. Buprenorphine is a partial opioid agonist that stabilizes the brain's opioid system without producing the highs and crashes of misuse, and taking a prescribed medication that lets you work, parent and stay alive is treatment, not addiction. Patients on buprenorphine have about half the overdose death rate of those who are not, and better retention in treatment than with any other approach. Length of treatment is individualized, and many people stay on it for years with good reason.

Nearby Stedfast offices

If you are in crisis, call or text 988 or go to the nearest emergency room. Educational content; individual results vary. Reviewed by Dr. David Husted, board-certified psychiatrist.

Substance Use and Addiction Psychiatry care in Melbourne

Tell us how to reach you and our scheduling team will help you explore appointment options. Most new patients are seen within one to two weeks, in person or by video. Medicare and most plans accepted; self-pay new-patient visits are $185.